TB-500 Complete Guide: Dosage, Protocols, Recovery Benefits (UK 2026)

TB-500 is a synthetic fragment of thymosin beta-4, a naturally occurring protein involved in tissue repair, cell migration, and angiogenesis throughout the body. Its distinguishing practical feature is its ability to distribute systemically from a single injection site — unlike BPC-157, which tends to act most powerfully near the injection site, TB-500 travels via the bloodstream and can promote healing in tissues distant from the injection point. This makes it particularly valuable for athletes dealing with multiple injury sites or injuries in areas that are impractical to inject locally.

What Is TB-500?

TB-500 is a synthetic version of a 43-amino acid peptide fragment of the naturally occurring protein thymosin beta-4 (Tβ4). The full thymosin beta-4 protein is involved in actin sequestration and cell mobility, and is released at sites of tissue injury in the body. The specific TB-500 fragment (residues 17–23 of the full Tβ4 sequence: Lys-Gly-Val-Leu-Thr-Lys-Lys-Thr) retains the critical biological activities associated with Tβ4's healing properties while being small enough for practical synthesis and administration.

Like BPC-157, TB-500 has not completed Phase III human clinical trials. Full thymosin beta-4 (not the TB-500 fragment) has been studied in human trials for cardiac repair following myocardial infarction. TB-500 itself lacks a completed human clinical trial record, and the evidence base is primarily animal-derived.

Mechanisms of Action

Actin Regulation and Cell Mobility

Thymosin beta-4 is one of the most abundant intracellular peptides in eukaryotic cells. Its primary physiological role is sequestering G-actin (globular actin) — regulating the pool of actin available for polymerisation into F-actin filaments. This is critical for cell migration: cells that need to move (e.g., white blood cells, endothelial cells migrating to form new blood vessels) require dynamic actin remodelling. TB-500's regulation of this process makes it a key facilitator of cell migration to injury sites.

Angiogenesis Promotion

TB-500 significantly promotes angiogenesis — the formation of new blood vessels — by stimulating endothelial cell proliferation and migration. Enhanced vascularity at injury sites dramatically improves healing by increasing oxygen and nutrient delivery and waste product removal.

Muscle Cell Differentiation and Satellite Cell Activation

TB-500 promotes the differentiation of satellite cells (muscle stem cells) into mature muscle fibres. This is directly relevant to the recovery from muscle tears and the regeneration of muscle tissue in athletes under high training stress.

Anti-Inflammatory Properties

Thymosin beta-4 modulates inflammatory cytokine signalling, reducing excessive inflammation at injury sites. This anti-inflammatory activity helps prevent the chronic low-grade inflammation that impairs healing and contributes to the overuse injuries common in strength athletes.

What TB-500 Is Used for in Practice

• Tendon and ligament injuries: Particularly for injuries that have failed to resolve with conventional rest and physiotherapy
• Overuse injury management: Chronic tendinopathy, bursitis, and joint irritation from repetitive loading
• Muscle tear recovery: Accelerating return to full training after partial or complete muscle tears
• General recovery enhancement: As a systemic protocol to reduce overall training-related tissue inflammation and improve recovery rate
• Heart health: Research on full thymosin beta-4 has shown cardiac protective and regenerative properties — whether TB-500 confers these is less established

TB-500 Dosing Protocol

Loading Phase (First 4–6 Weeks)

• Dose: 2–2.5 mg twice weekly (Monday/Thursday or similar split)
• Total weekly dose: 4–5 mg/week
• Route: Subcutaneous injection (any site — TB-500 distributes systemically)

Maintenance Phase (After 6 Weeks)

• Dose: 2–2.5 mg per week (single weekly injection)
• Duration: Continue for 4–8 additional weeks as needed

TB-500 + BPC-157 Combined Stack

• TB-500: 2–2.5 mg twice weekly (loading) OR once weekly (maintenance)
• BPC-157: 250–500 mcg daily (subcutaneous)
• Duration: 8–12 weeks total

See our BPC-157 complete guide for BPC-157 protocols and our complete peptides guide for context on the full peptide landscape. Browse TB-500 and all peptide products.

TB-500 vs BPC-157: Which Should You Choose?

Factor	TB-500	BPC-157
Distribution	Systemic (acts throughout body)	More localised (acts near injection site)
Best for	Multiple injury sites; systemic recovery; inaccessible injuries	Specific localised injury; gut health
Tendon healing	Strong evidence (animal)	Strong evidence (animal)
Muscle repair	Very good (satellite cell activation)	Good
Gut healing	Limited evidence	Excellent (original indication)
Dosing frequency	Twice weekly (loading); once weekly (maintenance)	Daily
Use together?	Yes — complementary mechanisms	Yes — complementary mechanisms

Reconstitution and Storage

TB-500 is typically supplied as lyophilised powder in 2 mg or 5 mg vials. Reconstitute with bacteriostatic water (not sterile water for multi-dose use). Add water gently down the inside of the vial; gently swirl to dissolve. Store reconstituted peptide refrigerated (2–8°C) and use within 28 days. Inject with a 27–31 gauge insulin syringe subcutaneously into abdominal fat.

Safety Profile

• No hormonal effects: TB-500 does not affect GH, IGF-1, testosterone, LH, FSH, or any other measured hormone in animal studies
• No HPG suppression: PCT not required
• Reported side effects: Mild fatigue or lethargy reported by some users, particularly in the first 1–2 weeks of loading doses. Typically resolves after the loading phase.
• Injection site reactions: Minor bruising possible
• Long-term human safety: Unknown — no long-term human data
• WADA status: TB-500 is listed as prohibited in competition under the peptide hormones and growth factors category. Athletes subject to anti-doping testing must avoid it.

Frequently Asked Questions

How long does TB-500 take to work?

Most athletes report noticeable improvement in injury symptoms within 2–4 weeks of loading doses. The anti-inflammatory effects may be felt earlier (within 1–2 weeks) than the structural tissue repair benefits (2–6 weeks). Chronic injuries of long standing may require longer treatment courses (8–12 weeks) for meaningful resolution.

Can TB-500 be used alongside anabolic steroids?

Yes — there are no documented pharmacological interactions. TB-500 is frequently used by athletes on anabolic steroid cycles to manage joint and connective tissue stress. It does not affect the hormonal systems that steroids target. See our safe steroid use guide for comprehensive harm reduction protocols.

Is TB-500 the same as thymosin beta-4?

No — TB-500 is a specific fragment (residues 17–23) of the full thymosin beta-4 (Tβ4) protein. Full Tβ4 has been studied in human cardiac trials. TB-500 is a more economical synthetic analogue that retains the key biologically active region of Tβ4 but is not identical to it.